Diagnosis, treatment and follow-up of diabetes mellitus in childhood and adolescence;Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter

Diabetologie und Stoffwechsel

Volumn 8, Issue SUPPL.2, 2013, Pages

  Neu, A ^a   Beyer, P ^b   Burger Busing J ^c   Danne, T ^d   Etspuler J ^e   Heidtmann, B ^f   Holl, R W ^g   Karges, B ^h   Kiess, W ⁱ   Knerr, I ^j   Kordonouri, O ^d   Lange, K ^l   Lepler, R ^m   Marg, W ⁿ   Nake A ^o   Petersen, M ^p   Podeswik, A ^q   Stachow, R ^r   Von Sengbusch, S ^p   Wagner, V ^p   Ziegler, R ^s   Holterhus, P M ^k   more..

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Evangelisches Krankenhaus Oberhausen   (Germany)

^c Bund Diabetischer Kinder und Jugendlicher EV   (Germany)

^d Diabetes Zentrum fur Kinder und Jugendliche   (Germany)

^e Altonaer Kinderkrankenhaus   (Germany)

^f Kindermedizinisches Versorgungszentrum Am Wilhelmstift   (Germany)

^g UNIVERSITY HOSPITAL ULM   (Germany)

^h UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

ⁱ UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^j UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^k UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^l HANNOVER MEDICAL SCHOOL   (Germany)

^m Katholisches Kinderkrankenhaus Wilhelmstift   (Germany)

ⁿ KLINIKUM BREMEN MITTE   (Germany)

^o UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^p UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^q beta Institut fur angewandtes Gesundheitsmanagement   (Germany)

^r Fachklinik Sylt für Kinder und Jugendliche der Deutschen Rentenversicherung Nord   (Germany)

^s Diabetologische Schwerpunktpraxis   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETES MELLITUS;

EID: 84887874014     PISSN: 18619002     EISSN: 18619010     Source Type: Journal    
DOI: 10.1055/s-0033-1350564     Document Type: Article

References (111)

1. Scherbaum W. A., Kerner W. Evidenzbasierte Leitlinie der DDG - Therapie des Diabetes mellitus Typ 1. In: Martin S., Dreyer M., Kiess W., Lüdecke H. J., Müller U. A., Schatz W. Deutsche Diabetes Gesellschaft (DDG).: 2007
2. Neu A., Willasch A., Ehehalt S. et al. Prävalenz und Altersverteilung des Diabetes mellitus im Kindesalter in Deutschland. Monatsschr Kinderheilkd: 2002; 150 196 200
3. Rosenbauer J., Icks A., Grabert M. et al. Hohe Prävalenz des Typ-1-Diabetes mellitus im Kindes- und Jugendalter in Deutschland (Abstract). Kinder-Jugendmed: 2002; 2
4. Ehehalt S., Blumenstock G., Willasch A. M. et al. Continuous rise in incidence of childhood Type 1 diabetes in Germany. Diabet Med: 2008; 25 755 757
5. Neu A., Ehehalt S., Willasch A. et al. Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0-14 years of age. Diabetes Care: 2001; 24 785 786
6. Rosenbauer J., Icks A., Schmitter D. et al. Incidence of childhood Type I diabetes mellitus is increasing at all ages in Germany. Diabetologia: 2002; 45 457 458
7. Kurth B. M., Schaffrath R. A. Die Verbreitung von Übergewicht und Adipositas bei Kindern und Jugendlichen in Deutschland. Ergebnisse des bundesweiten Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz: 2007; 50 736 743
8. Kromeyer-Hauschild K., Wabitsch M., Kunze D. et al. Perzentile für den Body-Mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd: 2001; 149 807 818
9. Rosenbauer J., Icks A., du Prel J. B. et al. Populationsbasierte Daten zur Inzidenz des Typ-2-Diabetes mellitus bei Kindern und Jugendlichen in Deutschland. Monatsschr Kinderheilkd: 2003; 151 71
10. Neu A., Feldhahn L., Ehehalt S. et al. Prevalence of type 2 diabetes and MODY in children and adolescents. A state-wide study in Baden-Wuerttemberg (Germany). Pediatr Diabetes: 2005; 6 27 28
11. Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005; EK IV
12. Gale E. A., Gillespie K. M. Diabetes and gender. Diabetologia: 2001; 44 3 15
13. Rosenbloom A. L., Schatz D. A., Krischer J. P. et al. Therapeutic controversy: prevention and treatment of diabetes in children. J Clin Endocrinol Metab: 2000; 85 494 522
14. Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005; EK I b
15. Arbeitsgemeinschaft Adipositas im Kindes- und Jugendalter (AGA) Leit?linien. Verabschiedet auf der Konsensus-Konferenz der AGA am 06.10.2008. Deutsche Adipositas-Gesellschaft: 2008
16. Bangstad H. J., Danne T., Deeb L. C. et al. Insulin treatment. ISPAD clinical practice consensus guidelines 2006-2007. Pediatr Diabetes: 2007; 8 88 102
17. Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005; EK II b-III
18. Rewers M., Pihoker C., Donaghue K. et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes: 2007; 8 408 418
19. Cranston I., Lomas J., Maran A. et al. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet: 1994; 344 283 287
20. Holl R. W., Heinze E. Dawn- oder Somogyi-Phänomen? Hohe morgendliche Nüchternblutzuckerwerte bei jugendlichen Typ-1-Diabetikern. Dtsch Med Wochenschr: 1992; 117 1503 1507
21. Hellems M. A., Clarke W. L. Safe at school: a Virginia experience. Diabetes Care: 2007; 30 1396 1398
22. American Diabetes Association (ADA) Diabetes care in the school and day care setting. Diabetes Care: 2007; 30 01 S66 S73
23. Nakhla M., Daneman D., Frank M. et al. Translating transition: a critical review of the diabetes literature. J Pediatr Endocrinol Metab: 2008; 21 507 516
24. Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005
25. Court J. M., Cameron F. J., Berg-Kelly K. et al. Diabetes in adolescence. Pediatr Diabetes: 2008; 9 255 262
26. Brink S., Laffel L., Likitmaskul S. et al. Sick day management in children and adolescents with diabetes. Pediatr Diabetes: 2007; 8 401 407
27. Diabetes Control and Complications Trial Research Group The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes: 1995; 44 968 983
28. White N. H., Sun W., Cleary P. A. et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol: 2008; 126 1707 1715
29. Nathan D. M., Cleary P. A., Backlund J. Y. et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med: 2005; 353 2643 2653
30. Musen G., Jacobson A. M., Ryan C. M. et al. Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial. Diabetes Care: 2008; 31 1933 1938
31. Bangstad H. J., Danne T., Deeb L. C. et al. Insulin treatment. ISPAD clinical practice consensus guidelines 2006-2007. Pediatr Diabetes: 2007; 8 88 102
32. Danne T., Becker R. H., Heise T. et al. Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes. Diabetes Care: 2005; 28 2100 2105
33. Mortensen H. B., Lindholm A., Olsen B. S. et al. Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes. Eur J Pediatr: 2000; 159 483 488
34. Deeb L. C., Holcombe J. H., Brunelle R. et al. Insulin lispro lowers postprandial glucose in prepubertal children with diabetes. Pediatrics: 2001; 108 1175 1179
35. Plank J., Siebenhofer A., Berghold A. et al. Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus. Arch Intern Med: 2005; 165 337 344
36. Simpson D., McCormack P. L., Keating G. M. et al. Insulin lispro: a review of its use in the management of diabetes mellitus. Drugs: 2007; 67 407 434
37. Danne T., Aman J., Schober E. et al. A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes. Diabetes Care: 2003; 26 2359 2364
38. Danne T., Datz N., Endahl L. et al. Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial. Pediatr Diabetes: 2008; 9 554 560
39. Thisted H., Johnsen S. P., Rungby J. An update on the long-acting insulin analogue glargine. Basic Clin Pharmacol Toxicol: 2006; 99 1 11
40. Robertson K. J., Schoenle E., Gucev Z. et al. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes. Diabet Med: 2007; 24 27 34
41. Phillip M., Battelino T., Rodriguez H. et al. Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care: 2007; 30 1653 1662
42. Aslander-van Vliet E., Smart C. et al. Nutritional management in childhood and adolescent diabetes. Pediatr Diabetes: 2007; 8 323 339
43. Mann J., de Leeuw I., Hermansen K. et al. Evidenz-basierte Ernährungsempfehlungen zur Behandlung und Prävention des Diabetes mellitus. Diabet Stoffw: 2005; 14 75 94
44. Deutsche Gesellschaft für Ernährung (DGE), Österreichische Gesellschaft für Ernährung (ÖGE), Schweizerische Gesellschaft für Ernährungsforschung (SGE), Schweizerische Vereinigung für Ernährung (SVE) Referenzwerte für die Nährstoffzufuhr. Neustadt/Weinstraβe Neuer Umschau Buchverl: 2008
45. Bloomgarden Z. T., Karmally W., Metzger M. J. et al. Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care: 1987; 10 263 272
46. de Weerdt I., Visser A. P., Kok G. J. et al. Randomized controlled multicentre evaluation of an education programme for insulin-treated diabetic patients: effects on metabolic control, quality of life, and costs of therapy. Diabet Med: 1991; 8 338 345
47. Lange K., Sassmann H., von Schütz W. et al. Prerequisites for age-appropriate education in type 1 diabetes: a model programme for paediatric diabetes education in Germany. Pediatr Diabetes: 2007; 8 06 63 71
48. Swift P. G. Diabetes education. ISPAD clinical practice consensus guidelines 2006-2007. Pediatr Diabetes: 2007; 8 103 109
49. Mensing C., Boucher J., Cypress M. et al. National standards for diabetes self-management education. Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs. Diabetes Care: 2000; 23 682 689
50. Funnell M. M., Brown T. L., Childs B. P. et al. National standards for diabetes self-management education. Diabetes Care: 2009; 32 Suppl 1 S87 S94
51. Bundesarbeitsgemeinschaft für Rehabilitation (BAR) Gemeinsames Rahmenkonzept der Gesetzlichen Krankenkassen und der Gesetzlichen Rentenversicherung für die Durchführung stationärer medizinischer Leistungen der Vorsorge und Rehabilitation für Kinder und Jugendliche. 2008; http://http://www.bar-frankfurt.de/upload/Rahmenkonzept.72dpi-435.pdf
52. Fröhlich C., Hermann T., Koch S. et al. Indikationen für eine stationäre Rehabilitation von Kindern und Jugendlichen mit Typ-1-Diabetes - eine bundesweite "DPV-Wiss-Analyse. Diabet Stoffw: 2008; 93
53. Verband Deutscher Rentenversicherungsträger (VDR) Rahmenkonzept zur medizinischen Rehabilitation von Kindern und Jugendlichen in der gesetzlichen Rentenversicherung. Empfehlungen des Verbandes Deutscher Rentenversicherungsträger. 1998; http://http://infomed.mds-ev.de/sindbad. nsf/f79a8096ad98496fc12571e700442be0/3ccf1982457e68f080256bc4003b2fa3/ $FILE/ATTS1QCV/VDR-KiJu-Reha-1998.pdf
54. Deutsche Gesellschaft für pädiatrische Rehabilitation und Prävention Leitlinie Rehabilitation Diabetes mellitus im Kindes- und Jugendalter. 2007; http://http://www.uni-duesseldorf.de/awmf/ll/070-003.htm
55. Stachow R., Koch S., Fröhlich C. et al. Effekte der stationären Rehabilitation von Kindern und Jugendlichen mit Diabetes mellitus Typ 1 - eine multizentrische DPV-Wiss-Analyse. Diabet Stoffw: 2008; 59
56. Stachow R., Schultz A., Kurzinsky U. et al. Anti-Streβ-Training für Kinder und Jugendliche mit Diabetes während der stationären Rehabilitation. Kindheit Entwicklung: 2001; 10 226 239
57. Delamater A. M. Psychological care of children and adolescents with diabetes. Pediatr Diabetes: 2007; 8 340 348
58. Forsander G., Persson B., Sundelin J. et al. Metabolic control in children with insulin-dependent diabetes mellitus 5y after diagnosis. Early detection of patients at risk for poor metabolic control. Acta Paediatr: 1998; 87 857 864
59. Hürter A., Otten A. Familien mit diabetischen Kindern und Jugendlichen: Psychische und soziale Probleme und der Wunsch nach psychologischer Hilfe im Vergleich mit anderen chronischen Erkrankungen. In: Roth R., Borkenstein M., eds. Psychosoziale Aspekte in der Betreuung von Kindern und Jugendlichen mit Diabetes. Basel Karger: 1991; 150 159
60. Sundelin J., Forsander G., Mattson S. E. Family-oriented support at the onset of diabetes mellitus: a comparison of two group conditions during 2 years following diagnosis. Acta Paediatr: 1996; 85 49 55
61. Delamater A. M., Bubb J., Davis S. G. et al. Randomized prospective study of self-management training with newly diagnosed diabetic children. Diabetes Care: 1990; 13 492 498
62. Rydall A. C., Rodin G. M., Olmsted M. P. et al. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med: 1997; 336 1849 1854
63. Bryden K. S., Neil A., Mayou R. A. et al. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care: 1999; 22 1956 1960
64. Nielsen S., Emborg C., Molbak A. G. Mortality in concurrent type 1 diabetes and anorexia nervosa. Diabetes Care: 2002; 25 309 312
65. Meltzer L. J., Johnson S. B., Prine J. M. et al. Disordered eating, body mass, and glycemic control in adolescents with type 1 diabetes. Diabetes Care: 2001; 24 678 682
66. Colton P., Olmsted M., Daneman D. et al. Disturbed eating behavior and eating disorders in preteen and early teenage girls with type 1 diabetes: a case-controlled study. Diabetes Care: 2004; 27 1654 1659
67. Liss D. S., Waller D. A., Kennard B. D. et al. Psychiatric illness and family support in children and adolescents with diabetic ketoacidosis: a controlled study. J Am Acad Child Adolesc Psychiatry: 1998; 37 536 544
68. Northam E. A., Matthews L. K., Anderson P. J. et al. Psychiatric morbidity and health outcome in Type 1 diabetes - perspectives from a prospective longitudinal study. Diabet Med: 2005; 22 152 157
69. Hood K. K., Huestis S., Maher A. et al. Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics. Diabetes Care: 2006; 29 1389 1391
70. Stewart S. M., Rao U., Emslie G. J. et al. Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus. Pediatrics: 2005; 115 1315 1319
71. Lawrence J. M., Standiford D. A., Loots B. et al. Prevalence and correlates of depressed mood among youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatrics: 2006; 117 1348 1358
72. Australasian Paediatric Endocrine Group, Department of Health and Ageing, National Health and Medical Research Council (NHMRC) Clinical practice guidelines: Type 1 diabetes in children and adolescents. 2005; EK III/IV
73. Glaser N. S., Wootton-Gorges S. L., Buonocore M. H. et al. Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diabetes: 2006; 7 75 80
74. Fiordalisi I., Novotny W. E., Holbert D. et al. An 18-yr prospective study of pediatric diabetic ketoacidosis: an approach to minimizing the risk of brain herniation during treatment. Pediatr Diabetes: 2007; 8 142 149
75. Wolfsdorf J., Craig M. E., Daneman D. et al. Diabetic ketoacidosis. Pediatr Diabetes: 2007; 8 28 43
76. Edge J. A., Jakes R. W., Roy Y. et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia: 2006; 49 2002 2009
77. Wolfsdorf J., Craig M. E., Daneman D. et al. Diabetic ketoacidosis. Pediatr Diabetes: 2007; 8 28 43
78. Hanas R., Lindgren F., Lindblad B. Diabetic ketoacidosis and cerebral oedema in Sweden - a 2-year paediatric population study. Diabet Med: 2007; 24 1080 1085
79. Roberts M. D., Slover R. H., Chase H. P. Diabetic ketoacidosis with intracerebral complications. Pediatr Diabetes: 2001; 2 109 114
80. Franklin B., Liu J., Ginsberg-Fellner F. Cerebral edema and ophthalmoplegia reversed by mannitol in a new case of insulin-dependent diabetes mellitus. Pediatrics: 1982; 69 87 90
81. Banks C. J., Furyk J. S. Review article: hypertonic saline use in the emergency department. Emerg Med Australas: 2008; 20 294 305
82. Clarke W., Jones T., Rewers A. et al. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes: 2008; 9 165 174
83. Diabetes Control and Complications Trial Research Group Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr: 1994; 125 177 188
84. Bangstad H. J., Danne T., Deeb L. C. et al. Insulin treatment. ISPAD clinical practice consensus guidelines 2006-2007. Pediatr Diabetes: 2007; 8 88 102
85. Silverstein J., Klingensmith G., Copeland K. et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care: 2005; 28 186 212
86. Hill I. D., Dirks M. H., Liptak G. S. et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr: 2005; 40 1 19
87. Silverstein J., Klingensmith G., Copeland K. et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care: 2005; 28 186 212
88. Kordonouri O., Maguire A. M., Knip M. et al. ISPAD Clinical Practice Consensus Guidelines 2006-2007. Other complications and associated conditions. Pediatr Diabetes: 2007; 8 171 176
89. Hansen D., Brock-Jacobsen B., Lund E. et al. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years' follow-up. Diabetes Care: 2006; 29 2452 2456
90. Amin R., Murphy N., Edge J. et al. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care: 2002; 25 1117 1122
91. Lewis H. M., Renaula T. L., Garioch J. J. et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol: 1996; 135 363 367
92. Genuth S., Alberti K. G., Bennett P. et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care: 2003; 26 3160 3167
93. Alberti G., Zimmet P., Shaw J. et al. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care: 2004; 27 1798 1811
94. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet: 1998; 352 837 853
95. Holman R. R., Paul S. K., Bethel M. A. et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med: 2008; 359 1577 1589
96. Shimazaki T., Kadowaki T., Ohyama Y. et al. Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Transl Res: 2007; 149 196 204
97. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet: 1998; 352 854 865
98. Jones K. L., Arslanian S., Peterokova V. A. et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care: 2002; 25 89 94
99. Gottschalk M., Danne T., Vlajnic A. et al. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care: 2007; 30 790 794
100. Ellard S., Bellanne-Chantelot C., Hattersley A. T. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia: 2008; 51 546 553
101. Badenhoop K., Kordonouri O., Machicao F. Empfehlungen zur molekulargenetischen Diagnostik bei Verdacht auf MODY. DDG: 2008
102. Hattersley A., Bruining J., Shield J. et al. ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children. Pediatr Diabetes: 2006; 7 352 360
103. Flanagan S. E., Edghill E. L., Gloyn A. L. et al. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia: 2006; 49 1190 1197
104. Babenko A. P., Polak M., Cave H. et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med: 2006; 355 456 466
105. Klupa T., Kowalska I., Wyka K. et al. Mutations in the ABCC8 gene are associated with a variable clinical phenotype. Clin Endocrinol (Oxf): 2008
106. Lanng S., Thorsteinsson B., Lund-Andersen C. et al. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr: 1994; 83 72 77
107. Nousia-Arvanitakis S., Galli-Tsinopoulou A., Karamouzis M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr: 2001; 90 515 519
108. Rolon M. A., Benali K., Munck A. et al. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr: 2001; 90 860 867
109. Dobson L., Hattersley A. T., Tiley S. et al. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child: 2002; 87 430 431
110. O'Riordan S. M., Robinson P. D., Donaghue K. C. et al. Management of cystic fibrosis-related diabetes. Pediatr Diabetes: 2008; 9 338 344
111. Man S. A., Andre J. L., de Bachmann H. et al. Blood pressure in childhood: pooled findings of six European studies. J Hypertens: 1991; 9 109 114b